6-Statistical Methods in Bioefficicacy Trials

Embed Size (px)

Citation preview

  • 8/3/2019 6-Statistical Methods in Bioefficicacy Trials

    1/16

    SOME STATISTICAL TECHNIQUES FOR BIO-EFFICACY TRIALS

    Rajender Parsad

    I.A.S.R.I., Library Avenue, New Delhi - 110 012

    Biological assays and probit analysis are quite useful in designing of bio-efficacy trialsand analysis of experimental data. A biological assay (bioassay) is a set of techniques

    relevant to the comparisons between the biological strength of alternative but similar

    biological stimuli (for example, a vitamin, a drug, a mental test, a physical force, aninsecticide, plant extract, etc.) based on the responses produced by them on the subjects,

    such as subhuman primates' (or human) living tissues, plants or isolated organs, insects,

    etc. Normally two preparations of the stimulus, one of known strength (standardpreparation) and another of unknown strength (test preparation), both with quantitativedoses are applied to a set of living organisms. The general objective of bioassays is to

    draw statistically valid conclusions on the relative potency of the test preparation with

    respect to the standard one. Usually when a drug or a stimulus is applied to a subject itinduces a change in some measurable characteristic that is designated as the response

    variable. In this setup, the dose may have several chemically or therapeutically different

    ingredients, while the response may also be multivariable. Thus the stimulus-response ordose-response relationships for the two preparations, both subject to inherent stochastic

    variability, are to be compared in a sound statistical manner so as to cast light on their

    relative performance with respect to the set objectives.

    Let ds and dtdenote the doses of the standard and the test preparations respectively such

    that each of them produces a pre-assigned response in some living organism. Then the

    ratio ts dd= is called the relative potency of the test preparation. If is greater than

    unity, it shows that a smaller dose of the test preparation produces as much response as arelatively larger dose of the standard preparation and hence the potency of the test

    preparation is greater than that of the standard preparation. Similarly when is less thanunity the potency of the test preparation is smaller than that of the standard preparation.

    Naturally, such statistical procedures may depend on the nature of the stimulus andresponse, as well as on other extraneous experimental (biological or therapeutic)

    considerations. As may be the case with some competing chemicals for removing the

    effect of common insects, the two (i.e. test and standard) preparations may not have thesame chemical or pharmacological constitution, and hence, statistical modeling may need

    a somewhat different approach than in common laboratory experimentation.

    Nevertheless, in many situations the test preparation may behave (in terms of theresponse/tolerance distribution) as if it is a dilution or concentration of the standard one.For this reason, often such bioassays are designated to compare the relative performance

    of two drugs under the dilution-concentration postulation (i.e., assays with two

    preparations containing the same effective ingredients which is responsible for theresponse), and are thereby termed dilution assays or analytical dilution assays. Dilution

    assays are classified into two broad categories: direct dilution and indirect dilution. In a

    direct assay, for each preparation the exact amount of dose needed to produce a specified

  • 8/3/2019 6-Statistical Methods in Bioefficicacy Trials

    2/16

    Some Statistical Techniques for Bio-Efficacy Trials

    VI-62

    response is directly measured, so that the response is certain while the dose is a non-negative random variable that defines the tolerance distribution. Statistical modeling of

    these tolerance distributions enables us to define the relative potency in a statistically

    interpretable and analyzable manner, often in terms of the parameters associated with thetolerance distributions. However, a direct assay is practicable only when both the

    preparations are capable of administration in such a way that the minimal amountsneeded to produce the specified response can directly be measured. In most assays,however, the response is not directly measurable and indirect methods are used to

    estimate the dose corresponding to a given response via a dose response relationship,

    such assays are known as indirect assays. In an indirect assay the dose is generally

    administered at some prefixed (usually non-stochastic) levels, and at each level theresponse is observed for subjects included in the study. Thus, the dose is generally non-

    stochastic and the stochastic response at each level provides information about the

    tolerance distribution for the particular preparation. If the response is a quantitativevariable (magnitude of some property like survival time, weight, etc.), then we have an

    indirect quantitative assay, while if the response is quantal in nature (i.e. all or nothing),

    then we have a quantal assay. Both of these assays are commonly adopted in statisticalpractice. Within this framework, the nature of the dose-response regression may call for

    suitable transformations on the dose variable (called the dosage or dosemetameter)

    and/or the response variable, called the response-metameter. The basic objective of such

    transformations is to achieve a linear dose-response regression that may inducesimplifications in statistical modeling and analysis schemes. Ifz represents the dose in

    the original scale, then the two transformations that have been found useful in bioassay

    work are (i) )z(logx e= and (ii)zx = , where 0> is a known constant. The first of

    these gives rise toparallel line assays and assays based on the second transformation are

    called as slope ratio assays. These assays normally fall under the category of

    quantitative indirect assays. In these assays, the transformation of response variable is

    generally not needed. In quantal assays, however, the response variable is generallysubjected to theprobit(or normit) and logittransformations, based on normal and logistic

    distributions, respectively.

    In a parallel line assay, the two dose-response regression lines (one for the standard

    preparation and another for the test preparation) are taken as parallel and further the

    errors in the two regression equations are assumed to have the same distribution (oftentaken as normal). Therefore, after fitting of these two regression lines, it is important to

    test for the parallelism for the regression lines before making any conclusions. A

    parallel line assay is called as symmetric if the standard and test preparations involve thesame number of doses, otherwise it is called an asymmetric assay. The analysis of the

    parallel line assay for conducting the validity tests and for estimating the relative potencybecomes very much simplified when the doses of each of the preparations are taken in

    geometric progression.

    In slope ratio assays it is assumed that the two regression lines intersect at the same point

    on the response axis, i.e., they are assumed to have the same intercept. As the dose takesvalue zero on the response axis, it is necessary to include a blank dose in the assay for the

    validity test. Thus if there are k doses for each of the two preparations in a slope ratio

  • 8/3/2019 6-Statistical Methods in Bioefficicacy Trials

    3/16

    Some Statistical Techniques for Bio-Efficacy Trials

    VI-63

    assay, the total number of doses is 2k+1. If against each of these doses an equal numberof subjects, say, n is allotted, the assay is 2k+1 symmetrical slope ratio assay, otherwise

    asymmetrical slope ratio assays. In slope ratio assays, the blank, the intersection

    contrasts and the two regression contrasts are of major importance.

    In quantal assays, occurrence or non-occurrence will depend upon the intensity of thestimulus. For any one subject, under controlled conditions there will be a certain level ofintensity below which the response does not occur and above which the response occurs.

    Such a value has often been called a thresholdor limen, but the term tolerance is now

    widely accepted. This tolerance value will vary from one member to another of the

    population used, frequently between quite wide limits. When the characteristic responseis quantitative, the stimulus intensity needed to produce a response of any given

    magnitude will show similar variation between individuals. In either case, the value for

    an individual also is likely to vary from one occasion to another as a result ofuncontrolled internal or external condition.

    In these assays, the earlier attempts were made to characterize the effectiveness of astimulus in relation to a quantal response referred to the minimal effective dose or for a

    more restricted class of stimuli, the minimal lethal dose terms which failed to take

    account of the variation in tolerance within a population. The logical weakness of such

    concepts is the assumption that there is a dose for any given chemical which is only justsufficient to kill all or most of the insects of a given species, and, doses a bit lesser would

    not kill any insect of that species. Any worker, however, accustomed to the estimation of

    toxicity knows that these assumptions do not represent the truth.

    It might be thought that the minimal lethal dose of a poison could instead be defined asthe dose just sufficient to kill a member of the species with the least possible tolerance,

    and also a maximal non-lethal dose as the dose which will just fail to kill the most

    resistant member. Undoubtedly some doses are so low that no test subject will succumbto them and others so high as to prove fatal at all, but considerable difficulties attend

    determination of the end-points of these ranges. Even when the tolerance of an individual

    can be measured directly, to say from measurements on a sample of ten or a hundred thatthe lowest tolerance found indicated the minimal lethal dose would be unwise: a larger

    sample might contain a more extreme member. When only quantal responses for selected

    doses can be recorded the difficulty is increased, and the occurrence of exceptional

    individuals in the batches at different dose levels may seriously bias the final estimates.The problem is in fact that of determining the dose at which the dose response curve for

    the whole population needs the 0% or 100% levels of kill and even a very large

    experiment could scarcely estimate these points with any accuracy.

    An escape from the dilemma can be made by giving attention to a different and more

    satisfactorily defined characteristics, the median lethal dose, or, as a more general term toinclude response other then death, the median effective dose. This is the dose that will

    produce a response in half the population. The median effective dose is commonly

    referred to as the ED 50, the more restricted concept of median lethal dose as the LD 50.Analogous symbols were used for doses effective for other proportions of the population,

  • 8/3/2019 6-Statistical Methods in Bioefficicacy Trials

    4/16

    Some Statistical Techniques for Bio-Efficacy Trials

    VI-64

    ED90 being the dose that causes 90% to respond. With a fixed total number of subjecteffective doses in the neighborhood of ED50 can usually be estimated more precisely

    then those for more extreme percentage levels and this is, therefore, particularly favoured

    in expressing the effectiveness of the stimulus. The ED50 alternatively be regarded asthe median of the tolerance distribution that is to say the level of tolerance such that

    exactly half the subjects lie on either side of it.

    The ED 50 or LD 50 can easily be calculated using the Probit Analysis. For doing this,

    we conduct an experiment on different doses of an insecticide applied under standardized

    conditions to samples of an insect species and record the number of insects killed and the

    number of insects exposed. Now the ratio of the number insects died (the subjectsresponded) to that of the number of insects exposed (subjects exposed) gives the

    probability or proportion (P) of the insects killed at a particular dose. Now this

    probability data is subjected to probit or logit transformation.

    Probit transformation is nothing but the 5 more than the normal equivalent deviate. In

    this transformation, we replace each of the observed proportions with the value ofstandard normal curve below which the observed proportion of the area is found. To

    avoid negative numbers, the constant 5 is usually added. For example, if half (0.5) of the

    subjects respond at a particular dose, the corresponding probit value is 0, since half of the

    area in a standard normal falls below a Z score of 0. When the constant 5 is added, thetransformed value for the proportion is 5. If the observed proportion is 0.95, the

    corresponding probit value is 1.64. Addition of the constant value of 5 makes this 6.64.

    Likewise, if 10% of the subjects respond, then the normal equivalent deviate is -1.29 andhence the probit value is 3.7.

    In the logit transformation, the observed proportion P is changed to

    ( )( ) 52

    1ln+

    PP

    The quantity ( )( )PP 1ln is called a logit. Division by 2 and addition of the constant 5 isdone to keep the values positive and to keep the two types of transformations on a similar

    scale. If the observed proportion is 0.5, the logit-transformed value is 0+5, the same as

    the probit-transformed value. Similarly, if the observed proportion is 0.95, the logit-transformed value is 6.47 (1.47+5). This differs somewhat from the corresponding probit

    value of 6.64. (In most situations, analyses based on logits and probits give very similar

    results.)

    The above is discussion about the transformation of the observed proportions. The dose

    are transformed to the logarithmic scale. When the experimental data on the relation

    between dose and proportion of the subjects responded have been obtained, either agraphical or a statistical approach in terms of fitting of response metameter-dose

    metameter linear regression relationship can be used to estimate the parameters.

  • 8/3/2019 6-Statistical Methods in Bioefficicacy Trials

    5/16

    Some Statistical Techniques for Bio-Efficacy Trials

    VI-65

    The graphical approach is rapid and sufficiently good for many purposes. In thisapproach, the probits are plotted against the dose-metameter, and a straight line is drawn

    by eye to fit the points as satisfactorily as possible. The line must be so drawn that the

    differences between the observed probit values and the probit values obtained by the lineat each value of dose metameter are as small as possible. The value of log ED 50 is

    estimated from this line asx at which probit value is 5. In the second approach, we fit asimple linear regression equation

    Probit ( iii ebxaP ++=) ,

    where iP is the observed proportion corresponding at close ix (usually the log of the dose

    is used instead of the actual dose), a and b are respectively the intercept and slope of the

    regression equation and ie is the random error. From the fitted regression equation, the

    log ED 50 (x) is obtained as that value for which probit value is 5.

    The goodness of fit of the model, the Pearsons chi-square goodness of fit test. For this

    we obtain the expected frequencies are obtained. The expected frequencies are the

    number of subjects responded and is obtained by obtaining the estimated Probit ( iP ) from

    the fitted model. Subtract 5 from he model. Now obtain the area under the normal curve

    below this point. This gives the percentage of the subjects responded. Now using thenumber of subjects tried, one can obtain the expected number of subjects responded

    ( ii Pn ) for the dose i. If ir is the corresponding observed number of the subjects affected,

    then we obtain, residuals as iii Pnr . Now the Pearson goodness of fit chi-square is

    obtained as)1(

    )( 2

    iii

    iii

    PPn

    Pnr

    . The degrees of freedom are equal to the number of doses

    minus he number of estimated parameters. To be clearer, consider the following examplefrom Finney (1971).

    Example 1: Finney (1971) gave a data representing the effect of a series of doses of

    carotene (an insecticide) when sprayed on Macrosiphoniella sanborni (some obscure

    insects). The Table below contains the concentration, the number of insects tested ateach dose, the proportion dying and the probit transformation (probit+5) of each of the

    observed proportions.

    Concentration

    (mg/1)

    No. of

    insects (n)

    No. of

    affected (r)

    %kill (P) Log

    concentration

    (x)

    Empirical

    probit

    10.2 50 44 88 1.01 6.18

    7.7 49 42 86 0.89 6.08

    5.1 46 24 52 0.71 5.053.8 48 16 33 0.58 4.56

    2.6 50 6 12 0.41 3.82

    0 49 0 0 - -

  • 8/3/2019 6-Statistical Methods in Bioefficicacy Trials

    6/16

  • 8/3/2019 6-Statistical Methods in Bioefficicacy Trials

    7/16

    Some Statistical Techniques for Bio-Efficacy Trials

    VI-67

    The above discussion relates to only one stimulus. If there is more than one stimulusvariables terms are added to the model for each of the stimuli. We get the regression

    coefficients and standard errors, intercept and standard error, Pearson goodness-of-fit chi-

    square, observed and expected frequencies, and confidence intervals for effective levelsof independent variable(s). If the Pearson goodness-of-fit chi-square is non-significant,

    we calculate the value of the dose-metameter for which the value of the responsemetameter (probit) is 5. The antilogarthmic of this dose metameter is the ED 50 or LD50.

    The ED 50 alone does not fully describe the effectiveness of the stimulus. Two

    insecticides/fungicides may require the same rate of application in order to be lethal tohalf of the population, but, if the distribution of tolerances has a lesser 'spread' for one

    than for the other, any increase or decrease from this rate will produce a greater change in

    mortality for the first than for the second. Therefore, it is necessary to give the standarderrors and fiducial limits associated with ED 50 or LD 50. Besides knowing the ED 50 of

    a particular chemical preparation, the experimenter may be interested in comparing the

    relative potencies of the several chemical preparations. One is required to fit the probitregression lines for each of the chemical preparations separately. These regression lines

    are required to be tested for parallelism. If the probit regression lines are parallel for the

    different chemical preparations, then the relative potency is constant at all levels of theresponse.

    The choice of an efficient experimental design is based on the nature of the variability in

    the experimental material, environmental conditions and objectives for conducting abioassay. The design may be a randomized complete block design, an incomplete block

    design, design for factorial experiments etc.

    Computation of corrected efficacy %

    The discussion earlier assumed that the responses of the test subjects is due to the appliedstimuli alone. In some experiments, however, the responses can occur at zero dose; either

    control batches of the subjects have received zero dose or a sequence of low doses

    indicating a minimal response rate greater than zero. In a pesticide trials some insectsmay die from natural causes. In such situations, it is required to work with crrected

    mortality or corrected proportions of the responses. Corrected efficacy % in pesticide

    trials can be computed by using the Abbott, Henderson and Tilton, Schneider-Orelli orSun-Shepard formulas. The selection of appropriate formula is depending on two factors

    viz.

    1. Trial condition (infestation or population stability and homogeneity).2. The data on your hand (live individuals or mortality %).

    The following table is of help in choosing the right formula

    Available data Uniform population Non-uniform population

    Infestation or live

    individualsAbbott Henderson-Tilton

    Mortality or dead

    individualsSchneider-Orelli Sun-Shepard

  • 8/3/2019 6-Statistical Methods in Bioefficicacy Trials

    8/16

    Some Statistical Techniques for Bio-Efficacy Trials

    VI-68

    These formulae are given in the sequel.

    Abbott's formula

    100*1

    =

    treatmentafterCoinn

    treatmentafterTinn%Corrected

    where : n = Insect population, T = treated, Co =control

    Henderson Tilton's formula

    100*treatmentbeforeTinn*treatmentafterCoinn

    treatmentafterTinn*treatmentbeforeCoinn1%Corrected

    =

    where : n = Insect population, T= treated, Co =control

    The above two formulae can be combined into one and written as

    Corrected % = 100

    x

    yx

    where x = % survivorship in the control group (concentration of pesticide=0)

    y = % survivorship in the experimental group.

    Schneider-Orelli's formula

    100*controlin%Mortality-100

    controlin%Mortality-in treatedMortality%%Corrected

    =

    Sun-Shepard's formula

    100*controlin%Change100

    controlin%changein treatedMortality%%Corrected

    +

    +=

    If the response is other than the death, then we may replace mortality by responded andsurvivorship by non-responded. Once the corrected responded % is obtained, then same

    procedure as above may be adoted.

    {This note is prepared from the book Probit Analysis by D. J. Finney (1971)}.

    Steps for carrying out the Probit Analysis using MINITAB

    For the data given in example 1, first enter the data in the Worksheet of MINITAB inthree coumns C1: dose; C2: total Insects; C3: Insects killed or affected. Now create a

    column C4 for logdose by using LOGT(C1) using menu Calc.

    Now Choose Stat > Reliability/Survival > Probit Analysis.

    From the dialog box; Choose the data format "Success/trial" or "Response/frequency". In

    the present case, the data is in success trial format, therefore, enter C3, the column

  • 8/3/2019 6-Statistical Methods in Bioefficicacy Trials

    9/16

    Some Statistical Techniques for Bio-Efficacy Trials

    VI-69

    containing the number of successes in Number of Successes box and C2, the total numberof trials in Number of Trials subbox. In the subbox for stress/stimulus enter C4, the

    column containing the logdose. Since, there is only one stimulus, therefore, the subbox

    pertaining to Factor (optional) may be left blank. Choose the distribution as normal.

    The other options available on the dialog box are: Estimate, Graphs, Options, Results and

    Storage.

    Using the option Estimate, One can

    - estimate percentiles for the percents you specify. These percentiles are added to thedefault table of percentiles.

    - estimate survival probabilities for the stress values you specify.

    One can also change the method of estimation for the confidence intervals and the levelof confidence. The default option is two sided 95% fiducial intervals.

    Other options may also be used, as and when required. For this example, we chose the

    additional percentiles as 65 and survival probabilities for stress level 0.9 (logdose).

    Probit Analysis: affect, total versus logdoseDistribution: Normal

    Response Information

    Variable Value Count

    affect Success 132

    Failure 111

    total Total 243

    Estimation Method: Maximum Likelihood

    Regression Table

    Standard

    Variable Coef Error Z P

    Constant -2.88746 0.350134 -8.25 0.000

    logdose 4.21320 0.478303 8.81 0.000

    Log-Likelihood = -120.052

    Goodness-of-Fit Tests

    Method Chi-Square DF P

    Pearson 1.72888 3 0.631

    Deviance 1.73897 3 0.628

    Tolerance Distribution: Parameter Estimates

    Standard 95.0% Normal CI

    Parameter Estimate Error Lower Upper

    Mean 0.685338 0.0220962 0.642030 0.728646

    StDev 0.237349 0.0269451 0.190001 0.296497

  • 8/3/2019 6-Statistical Methods in Bioefficicacy Trials

    10/16

    Some Statistical Techniques for Bio-Efficacy Trials

    VI-70

    Table of Percentiles

    Standard 95.0% Normal CI

    Percent Percentile Error Lower Upper

    1 0.133180 0.0686394 -0.0013503 0.267711

    2 0.197882 0.0617254 0.0769020 0.318861

    3 0.238933 0.0573944 0.126442 0.351423

    4 0.269813 0.0541723 0.163638 0.375989

    5 0.294933 0.0515787 0.193840 0.396025

    6 0.316313 0.0493935 0.219504 0.413123

    7 0.335060 0.0474969 0.241967 0.428152

    8 0.351845 0.0458160 0.262047 0.441643

    9 0.367110 0.0443030 0.280278 0.453943

    10 0.381162 0.0429251 0.297031 0.465294

    20 0.485580 0.0332991 0.420314 0.550845

    30 0.560872 0.0274617 0.507048 0.614696

    40 0.625206 0.0238086 0.578542 0.671870

    50 0.685338 0.0220962 0.642030 0.728646

    60 0.745470 0.0224241 0.701519 0.789420

    65 0.776793 0.0233958 0.730939 0.822648

    70 0.809804 0.0249330 0.760936 0.858672

    80 0.885096 0.0299366 0.826422 0.943771

    90 0.989513 0.0389715 0.913131 1.06590

    91 1.00357 0.0402991 0.924581 1.08255

    92 1.01883 0.0417626 0.936978 1.10068

    93 1.03562 0.0433947 0.950564 1.12067

    94 1.05436 0.0452427 0.965688 1.14304

    95 1.07574 0.0473792 0.982882 1.16860

    96 1.10086 0.0499232 1.00301 1.1987197 1.13174 0.0530936 1.02768 1.23580

    98 1.17279 0.0573685 1.06035 1.28523

    99 1.23750 0.0642153 1.11164 1.36336

    Table of Survival Probabilities

    95.0% Normal CI

    Stress Probability Lower Upper

    0.9 0.182888 0.122757 0.258650

    Interpretation: The goodness-of-fit tests (p-values = 0.631, 0.628) suggest that the

    distribution and the model fits the data adequately. In this case, the fitting is done onnormal equivalent deviate only without adding 5. Therefore, log LD50 or lof ED50

    corresponds to the value of Probit=0.Log LD50 is obtained as 0.685338. Therefore, the

    stress level at which the 50% of the insects will be killed is (100.685338=4.845 mg/l).

    Similarly the stress level at which 65% of the insects will be killed is (100.776793

    = 5.981mg/l). At logdose = 0.9, what percentage of insects will be killed? Results indicate that

    18.29% of the insects will be killed.

  • 8/3/2019 6-Statistical Methods in Bioefficicacy Trials

    11/16

    Some Statistical Techniques for Bio-Efficacy Trials

    VI-71

    Example 2: {Finney (1971): Ex.13} reported an experiment conducted to compare therelative potencies of the three analgesic amidone, phenadoxone and pethidine with

    morphine. The technique was to record how many standard electric shocks could be

    applied to the tail of a mouse before the mouse squeaked; if the number of shocksincreased by 4 or more after application of the drug, then we say that the mouse has

    responded. The data generated alongwith the log dose concentration is given thefollowing table.

    Factor Log dose Total Mouse Observed Mouse Responded

    (f) (x) (n) (r)

    1 0.18 103 191 0.48 120 53

    1 0.78 123 83

    2 0.18 60 142 0.48 110 54

    2 0.78 100 81

    3 -0.12 90 313 0.18 80 543 0.48 90 80

    4 0.70 60 13

    4 0.88 85 274 1.00 60 32

    4 1.18 90 55

    4 1.30 60 44

    1: morphine; 2:amidone; 3: phenadoxone; 4: pethidine.

    For the analysis of data follow the same steps as in Example 1 with the addition that in

    the factor subbox define factor as f. The results obtained are given in the sequel.

  • 8/3/2019 6-Statistical Methods in Bioefficicacy Trials

    12/16

    Some Statistical Techniques for Bio-Efficacy Trials

    VI-72

    Probit Analysis: r, n versus x, f

    Distribution: Normal

    Response Information

    Variable Value Count

    r Success 640

    Failure 591

    n Total 1231

    Factor Information

    Factor Levels Values

    f 4 1, 2, 3, 4

    Estimation Method: Maximum Likelihood

    Regression Table

    Standard

    Variable Coef Error Z P

    Constant -1.38969 0.114661 -12.12 0.000

    x 2.47552 0.173176 14.29 0.000

    f

    2 0.237877 0.108353 2.20 0.028

    3 1.35900 0.129801 10.47 0.000

    4 -1.18220 0.132956 -8.89 0.000

    Test for equal slopes: Chi-Square = 1.54180 DF = 3 P-

    Value = 0.673

    Log-Likelihood = -729.327

    Multiple degree of freedom test

    Term Chi-Square DF P

    f 185.015 3 0.000

    Goodness-of-Fit Tests

    Method Chi-Square DF P

    Pearson 4.03105 9 0.909

    Deviance 4.03534 9 0.909

  • 8/3/2019 6-Statistical Methods in Bioefficicacy Trials

    13/16

    Some Statistical Techniques for Bio-Efficacy Trials

    VI-73

    f = 1: Tolerance Distribution

    Parameter Estimates

    Standard 95.0% Normal CI

    Parameter Estimate Error Lower Upper

    Mean 0.561374 0.0291474 0.504247 0.618502

    StDev 0.403956 0.0282589 0.352198 0.463319

    Table of Percentiles

    Standard 95.0% Fiducial CI

    Percent Percentile Error Lower Upper

    1 -0.378367 0.0689837 -0.533080 -0.257945

    2 -0.268249 0.0620774 -0.407031 -0.159538

    3 -0.198383 0.0578001 -0.327263 -0.0968963

    4 -0.145825 0.0546499 -0.267390 -0.0496399

    5 -0.103073 0.0521384 -0.218789 -0.0111000

    6 -0.0666851 0.0500422 -0.177503 0.0217857

    7 -0.0347796 0.0482399 -0.141375 0.0506903

    8 -0.0062121 0.0466576 -0.109088 0.0766335

    9 0.0197689 0.0452472 -0.0797814 0.100284

    10 0.0436845 0.0439754 -0.0528570 0.122108

    20 0.221397 0.0355803 0.145115 0.286370

    30 0.349540 0.0312437 0.284438 0.408244

    40 0.459033 0.0292557 0.400035 0.515829

    50 0.561374 0.0291474 0.504555 0.619913

    60 0.663715 0.0307532 0.605621 0.727451

    70 0.773209 0.0340907 0.710494 0.845760

    80 0.901352 0.0395535 0.830116 0.987334

    90 1.07906 0.0488712 0.992544 1.1871491 1.10298 0.0502282 1.01420 1.21423

    92 1.12896 0.0517234 1.03768 1.24371

    93 1.15753 0.0533905 1.06346 1.27616

    94 1.18943 0.0552784 1.09219 1.31246

    95 1.22582 0.0574616 1.12491 1.35392

    96 1.26857 0.0600631 1.16327 1.40270

    97 1.32113 0.0633085 1.21034 1.46276

    98 1.39100 0.0676909 1.27277 1.54273

    99 1.50112 0.0747255 1.37093 1.66903

  • 8/3/2019 6-Statistical Methods in Bioefficicacy Trials

    14/16

    Some Statistical Techniques for Bio-Efficacy Trials

    VI-74

    f = 2: Tolerance Distribution

    Parameter Estimates

    Standard 95.0% Normal CI

    Parameter Estimate Error Lower Upper

    Mean 0.465283 0.0329958 0.400612 0.529953

    StDev 0.403956 0.0282589 0.352198 0.463319

    Table of Percentiles

    Standard 95.0% Fiducial CI

    Percent Percentile Error Lower Upper

    1 -0.474459 0.0766704 -0.646325 -0.340552

    2 -0.364341 0.0697856 -0.520318 -0.242102

    3 -0.294474 0.0655120 -0.440558 -0.179453

    4 -0.241917 0.0623566 -0.380675 -0.132207

    5 -0.199165 0.0598338 -0.332051 -0.0936894

    6 -0.162777 0.0577218 -0.290734 -0.0608351

    7 -0.130871 0.0558997 -0.254566 -0.0319695

    8 -0.102304 0.0542942 -0.222234 -0.0060724

    9 -0.0763229 0.0528573 -0.192875 0.0175260

    10 -0.0524073 0.0515559 -0.165892 0.0392905

    20 0.125305 0.0427040 0.0329891 0.202644

    30 0.253448 0.0376004 0.173847 0.322983

    40 0.362942 0.0345099 0.291660 0.428352

    50 0.465283 0.0329958 0.399014 0.529602

    60 0.567624 0.0330004 0.503306 0.633914

    70 0.677117 0.0346823 0.611508 0.748895

    80 0.805260 0.0385371 0.734347 0.887252

    90 0.982973 0.0462875 0.899894 1.0839491 1.00689 0.0474826 0.921870 1.11071

    92 1.03287 0.0488128 0.945680 1.13986

    93 1.06144 0.0503107 0.971790 1.17198

    94 1.09334 0.0520233 1.00087 1.20793

    95 1.12973 0.0540229 1.03395 1.24902

    96 1.17248 0.0564284 1.07270 1.29741

    97 1.22504 0.0594584 1.12019 1.35705

    98 1.29491 0.0635920 1.18312 1.43653

    99 1.40502 0.0703037 1.28191 1.56220

  • 8/3/2019 6-Statistical Methods in Bioefficicacy Trials

    15/16

    Some Statistical Techniques for Bio-Efficacy Trials

    VI-75

    f = 3: Tolerance Distribution

    Parameter Estimates

    Standard 95.0% Normal CI

    Parameter Estimate Error Lower Upper

    Mean 0.0123990 0.0356207 -0.0574164 0.0822144

    StDev 0.403956 0.0282589 0.352198 0.463319

    Table of Percentiles

    Standard 95.0% Fiducial CI

    Percent Percentile Error Lower Upper

    1 -0.927342 0.0819421 -1.11109 -0.784282

    2 -0.817224 0.0750288 -0.985032 -0.685889

    3 -0.747358 0.0707272 -0.905217 -0.623295

    4 -0.694800 0.0675438 -0.845278 -0.576104

    5 -0.652049 0.0649928 -0.796599 -0.537642

    6 -0.615660 0.0628521 -0.755225 -0.504845

    7 -0.583755 0.0610006 -0.718999 -0.476037

    8 -0.555188 0.0593651 -0.686607 -0.450199

    9 -0.529206 0.0578974 -0.657187 -0.426662

    10 -0.505291 0.0565644 -0.630141 -0.404960

    20 -0.327579 0.0473402 -0.430521 -0.242346

    30 -0.199436 0.0417348 -0.288661 -0.123009

    40 -0.0899420 0.0379801 -0.169516 -0.0189715

    50 0.0123990 0.0356207 -0.0604621 0.0805777

    60 0.114740 0.0346077 0.0458819 0.182837

    70 0.224234 0.0351438 0.156392 0.295510

    80 0.352377 0.0377872 0.281665 0.431433

    90 0.530089 0.0442858 0.449713 0.62562091 0.554004 0.0453498 0.471950 0.652131

    92 0.579986 0.0465463 0.496026 0.681012

    93 0.608553 0.0479071 0.522408 0.712859

    94 0.640458 0.0494781 0.551772 0.748529

    95 0.676847 0.0513295 0.585143 0.789329

    96 0.719598 0.0535776 0.624204 0.837409

    97 0.772156 0.0564359 0.672038 0.896705

    98 0.842022 0.0603728 0.735353 0.975800

    99 0.952140 0.0668332 0.834640 1.10097

  • 8/3/2019 6-Statistical Methods in Bioefficicacy Trials

    16/16

    Some Statistical Techniques for Bio-Efficacy Trials

    VI-76

    f = 4: Tolerance Distribution

    Parameter Estimates

    Standard 95.0% Normal CI

    Parameter Estimate Error Lower Upper

    Mean 1.03893 0.0281126 0.983832 1.09403

    StDev 0.403956 0.0282589 0.352198 0.463319

    Table of Percentiles

    Standard 95.0% Fiducial CI

    Percent Percentile Error Lower Upper

    1 0.0991908 0.0704720 -0.0590689 0.222048

    2 0.209309 0.0634814 0.0671458 0.320289

    3 0.279175 0.0591380 0.147044 0.382800

    4 0.331733 0.0559298 0.207031 0.429942

    5 0.374484 0.0533648 0.255738 0.468376

    6 0.410873 0.0512180 0.297124 0.501162

    7 0.442778 0.0493668 0.333349 0.529970

    8 0.471345 0.0477370 0.365730 0.555819

    9 0.497327 0.0462798 0.395129 0.579377

    10 0.521242 0.0449617 0.422145 0.601109

    20 0.698954 0.0361002 0.621045 0.764443

    30 0.827097 0.0312579 0.761380 0.885305

    40 0.936591 0.0287349 0.878053 0.991814

    50 1.03893 0.0281126 0.983610 1.09486

    60 1.14127 0.0292822 1.08555 1.20152

    70 1.25077 0.0322921 1.19109 1.31917

    80 1.37891 0.0375327 1.31115 1.4603090 1.55662 0.0467137 1.47385 1.65984

    91 1.58054 0.0480609 1.49552 1.68691

    92 1.60652 0.0495471 1.51903 1.71637

    93 1.63509 0.0512059 1.54482 1.74881

    94 1.66699 0.0530861 1.57357 1.78509

    95 1.70338 0.0552625 1.60629 1.82653

    96 1.74613 0.0578580 1.64467 1.87530

    97 1.79869 0.0610984 1.69175 1.93535

    98 1.86856 0.0654773 1.75419 2.01532

    99 1.97867 0.0725110 1.85234 2.14162

    Interpretation: The goodness-of-fit tests (p-values = 0.909) suggest that the distributionand model fits the data adequately. The test for equal slopes is not significant (p-value =

    0.673). The log ED50 for the four analgesics are 0.561374, 0.465283, 0.0123990 and

    1.03893. ED50 values are 3.642286, 2.919329, 1.028961, 10.9378 . The relative potenciescan easily be worked out.